Allergan plc (AGN) Fundamentals

Allergan PLC is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. The products offered by the company include Botox, Celexa, Fetzima, Refresh, Ozurdex and Zenpep among others.
SHARE INFORMATION
Market Cap$ 63,659,113,779
Shares Outstanding329,805,791
Float329,531,606
Percent Float99.92%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 2.96
Latest Fiscal Revenue$ 16,088,900,000
Latest Fiscal EPS$ -16.00
Latest Fiscal Date2019-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date2020-04-15
Dividend Rate$ 2.96
Dividend Yield1.53%
Payment CashCash
HOLDERS
Institutions2,005
Institutional Holdings Date2020-04-30
Institutional Bought Previous 3 Months36,480,132
Institutional Holdings Percent125.9%
Institutional Sold Previous 3 Months83,846,488
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned2,344,960
TRADING INFO
52 Week High$ 202.22
52 Week Low$ 114.27
52 Week High Change$ 54.33
21 Day Moving Average$ 193.02
21 Day Extended Moving Average$ 192.3019
50 Day Moving Average$ 188.1575
50 Day Extended Moving Average$ 189.7056
200 Day Moving Average$ 181.2949
200 Day Extended Moving Average$ 180.2726
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume1,796,805
50 Day Average Volume2,712,534
Alpha-0.011302
Beta1.1997
Standard Deviation0.095932
R20.288556
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 16.62
Quarter to Date Percent Change9.42%
180 Day Price Change$ 9.16
180 Day Percent Change4.98%
200 Day Price Change$ 10.63
200 Day Percent Change5.83%
Year to Date Price Change$ 3.30
Year to Date Percent Change1.74%

Allergan plc (AGN) Key Ratios

PROFITABILITY
EBIT Margin-20.9%
EBITDA Margin17.7%
Pre-Tax Profit Margin-34.7%
Profit Margin Count-15.4%
Gross Margin83.7%
Profit Margin TOT-15.4%
INCOME STATEMENTS
Revenue$ 16,096,200,000
Revenue Per Share$ 48.8051
Revenue (3 Years)$ 0.89
Revenue (5 Years)$ 1.55
FINANCIAL STRENGTH
Price to Tangible Book-3.30
Total Debt To Equity0.40
Int Coverage-4.40
Current Ratio1.00
Leverage Ratio1.60
Quick Ratio0.70
Long Term Debt To Capital0.24
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 81,526,058,278
Price to Sales3.9549
Price to Free Cash14.50
PE High Last 5 Years0.00
Price To Book1.10
Price To Cash Flow10.40
PE Low Last 5 Years0.00
Price to Tangible Book-3.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.30
Invoice Turnover2.10
Assets Turnover0.10
Return Assets-2.67
Return on Equity-4.16
Return on Capital-2.53

Allergan plc (AGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEO-
Emplyoees17400
Last AuditUE
CIK0001578845
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressClonshaugh Business and Technology Park
Coolock
Dublin, D17E400
Websitehttp://www.allergan.com
Facsimile-
Telephone+353 8622617000
Emailinvestorrelations@allergan.com
Your Recent History
NYSE
AGN
Allergan
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220814 23:55:43